NOVOZYMES BIOINDUSTRIAL A/S: Financial statements 2021
CVR: 24257908
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
NOVOZYMES BIOINDUSTRIAL A/S (CVR 24257908) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -32,188 and a net result of DKK 637,465 compared with DKK 2,470,893 the year before. Equity in the 2021 report amounted to DKK 29,474,482. The solvency ratio was 91.3%.
- Gross Profit
- DKK -32,188
- Profit/Loss
- DKK 637,465
- Equity
- DKK 29,474,482
- Total Assets
- DKK 32,270,028
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -32K | 637K | 29.5M | 0 |
| 2020 | - | -32K | 2.5M | 28.8M | 0 |
| 2019 | - | -38K | -32K | 26.4M | 0 |
| 2018 | - | -58K | -4.8M | 26.4M | - |
| 2017 | - | -74K | -5.4M | 1.2M | - |
Official annual report
Find more companies like NOVOZYMES BIOINDUSTRIAL A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
NOVOZYMES BIOINDUSTRIAL A/S has published its annual report for 2020. Gross profit came to DKK -31,604, and the net result was DKK 2,470,893.
As of January 18, 2021, Lars Green has joined the board of directors of NOVOZYMES BIOINDUSTRIAL A/S.
As of January 18, 2021, Randi Camilla Kinch Jensen has joined the board of directors of NOVOZYMES BIOINDUSTRIAL A/S.
As of January 18, 2021, Tina Sejersgård Fanø has left the board of directors of NOVOZYMES BIOINDUSTRIAL A/S.
As of January 18, 2021, Andrew Patrick Fordyce has left the board of directors of NOVOZYMES BIOINDUSTRIAL A/S.
About NOVOZYMES BIOINDUSTRIAL A/S
NOVOZYMES BIOINDUSTRIAL A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named NOVO NORDISK BIOINDUSTRIAL A/S and NOVO ENZYM A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,056 and a net result of DKK -44,180 compared with DKK -41,700 the year before. Equity in the 2025 report amounted to DKK 24,891,057.